LNAI — Lunai Bioworks Income Statement
0.000.00%
Last trade - 00:00- $25.07m
- $26.60m
Annual income statement for Lunai Bioworks, fiscal year end - June 30th, USD millions except per share, conversion factor applied.
2021 June 30th | 2022 June 30th | 2023 June 30th | R2024 June 30th | 2025 June 30th | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Revenue | |||||
| Total Revenue | 0 | 0 | 0 | 0 | 0 |
| Selling / General / Administrative Expenses | |||||
| Research And Development | |||||
| Depreciation and Amortization | |||||
| Unusual Expense / Income | |||||
| Total Operating Expenses | 23.4 | 116 | 39 | 82.9 | 189 |
| Operating Profit | -23.4 | -116 | -39 | -82.9 | -189 |
| Total Net Non Operating Interest Income / Expense | |||||
| Total Net Non Operating Interest Income / Expense | |||||
| Other Net Non Operating Costs | |||||
| Net Income Before Taxes | -26.8 | -113 | -39.7 | -88.4 | -178 |
| Provision for Income Taxes | |||||
| Net Income After Taxes | -26.7 | -113 | -39.7 | -88.4 | -178 |
| Net Income Before Extraordinary Items | |||||
| Net Income | -26.7 | -113 | -39.7 | -88.4 | -178 |
| Income Available to Common Shareholders Excluding Extraordinary Items | |||||
| Income Available to Common Shareholders Including Extraordinary Items | |||||
| Diluted Net Income | -26.7 | -113 | -39.7 | -88.4 | -178 |
| Diluted Weighted Average Shares | |||||
| Basic EPS Including Extraordinary Items | |||||
| Diluted EPS Including Extraordinary Items | |||||
| Diluted EPS Excluding Extraordinary Items | |||||
| Normalised Income Before Taxes | |||||
| Normalised Income After Taxes | |||||
| Normalised Income Available to Common Shareholders | |||||
| Diluted Normalised EPS | -5.67 | -10.1 | -3.61 | -3.25 | -0.46 |